Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 8.02%
March 31, 2026 -235.6%
December 31, 2025 28.93%
September 30, 2025 46.48%
June 30, 2025 56.46%
March 31, 2025 26.51%
December 31, 2024 -147.6%
September 30, 2024 -59.54%
June 30, 2024 7.25%
March 31, 2024 -28.14%
December 31, 2023 -103.2%
September 30, 2023 -397.5%
June 30, 2023 -54.84%
March 31, 2023 50.45%
December 31, 2022 53.34%
September 30, 2022 30.08%
June 30, 2022 45.62%
March 31, 2022 -0.45%
December 31, 2021 -314.8%
September 30, 2021 -50.76%
June 30, 2021 61.84%
March 31, 2021 63.37%
December 31, 2020 63.50%
September 30, 2020 12.81%
June 30, 2020 -55.29%
Date Value
March 31, 2020 -11.39%
December 31, 2019 -29.76%
September 30, 2019 37.47%
June 30, 2019 29.17%
March 31, 2019 59.67%
December 31, 2018 -604.4%
September 30, 2018 -34.60%
June 30, 2018 22.01%
March 31, 2018 -23.52%
September 30, 2017 -18.71%
June 30, 2017 5.04%
March 31, 2017 -1.99%
December 31, 2016 24.91%
September 30, 2016 34.01%
June 30, 2016 13.66%
March 31, 2016 12.59%
December 31, 2015 -130.6%
September 30, 2015 30.64%
June 30, 2015 34.34%
March 31, 2015 50.74%
December 31, 2014 -0.54%
September 30, 2014 37.45%
June 30, 2014 34.54%
March 31, 2014 56.33%
December 31, 2013 20.83%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
MedMira, Inc. -26.66%
MedX Health Corp. 27.96%
VentriPoint Diagnostics Ltd. -258.1%
Theralase Technologies, Inc. 21.12%
Profound Medical Corp. 78.41%

Gross Profit Margin (Quarterly) Related Metrics